The Cooper Companies, Inc. (COO)


+0.48 (+0.15%)
Symbol COO
Price $328.87
Beta 0.906
Volume Avg. 0.26M
Market Cap 16.287B
Shares () -
52 Week Range 244.22-399.62
1y Target Est -
DCF Unlevered COO DCF ->
DCF Levered COO LDCF ->
ROE 3.74% Neutral
ROA 2.35% Neutral
Operating Margin -
Debt / Equity 34.46% Neutral
P/E 59.58 Strong Buy
P/B 2.16 Strong Buy


Consensus EPS

Upgrades & Downgrades

Latest COO news

Mr. Albert G. White III
Medical Instruments & Supplies
New York Stock Exchange

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.